Search Login Register
quinagolide
Summary
88
relevant articles (16 outcomes,
17 trials/studies)
found for this Bio-Agent
Description:
structure & RN given in first source; a non-ergot dopamine D(2)-agonist
Also Known As:
CV 205-502; CV-205-502; CV205-502; N,N-diethyl-N'-(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propyl-3-benzo(g)quinolinyl)sulfamide hydrochloride, (3alpha,4aalpha,10abeta)-(+)-isomer; N,N-diethyl-N'-(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propyl-3-benzo(g)quinolinyl)sulfamide, (3alpha,4aalpha,10abeta)-(+-)-isomer Show All >>
Key Diseases for which quinagolide is
Relevant
-
Prolactinoma (Prolactinomas)
:
12 outcomes 8 studies in 39 results
-
Neoplasms (Cancer)
:
5 outcomes 3 studies in 22 results
-
Hyperprolactinemia
:
2 outcomes 2 studies in 16 results
-
Pituitary Neoplasms (Pituitary Adenoma)
:
1 outcome 1 study in 13 results
-
Parkinson Disease (Parkinson's Disease)
:
1 outcome 1 study in 2 results
Show All >>
Drugs Related to quinagolide
-
Dopamine Agonists (Dopamine Agonist)
-
Bromocriptine (Parlodel)
-
quinagolide
-
Prolactin
-
Dopamine (Intropin)
-
cabergoline
-
Lisuride
-
3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamide
-
Growth Hormone (Somatotropin)
-
Dopamine D2 Receptors (Dopamine D2 Receptor)
Show All >>
Therapies Related to quinagolide
-
Craniotomy
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.